Novel peptide-directed liposomes for targeted combination therapy of breast tumors
Open Access
- 4 November 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 1 (9) , 3483-3495
Abstract
PLipo-DOX–ICG demonstrates active targeting behavior for delivery and controllable release of chemotherapeutic drugs to CXCR4-overexpressing tumor ccells.Keywords
Funding Information
- National Natural Science Foundation of China (51861135103, 21721002, 21673055, 21790394, 81870133)
- National Key Research and Development Program of China (2017YFA0205001, 2017YFA0205504)
- Chinese Academy of Sciences (QYZDJ-SSW-SLH048)
- Chinese Academy of Medical Sciences (CIFMS 2016-I2M-3-004)
This publication has 34 references indexed in Scilit:
- Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapyAsian Journal of Pharmaceutical Sciences, 2019
- Engineering liposomal nanoparticles for targeted gene therapyGene Therapy, 2017
- Cancer nanomedicine: progress, challenges and opportunitiesNature Reviews Cancer, 2016
- Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenograftsJournal of Controlled Release, 2015
- Nanoparticle-induced vascular blockade in human prostate cancerBlood, 2010
- Anti-CD4-targeted Gold Nanoparticles Induce Specific Contrast Enhancement of Peripheral Lymph Nodes in X-ray Computed Tomography of Live MiceNano Letters, 2010
- Targeting of drugs and nanoparticles to tumorsJournal of Cell Biology, 2010
- Targeted drug delivery crossing cytoplasmic membranes of intended cells via ligand-grafted sterically stabilized liposomesJournal of Controlled Release, 2006
- High interstitial fluid pressure — an obstacle in cancer therapyNature Reviews Cancer, 2004
- Transport of Molecules, Particles, and Cells in Solid TumorsAnnual Review of Biomedical Engineering, 1999